SCHEMBL29370613

SCHEMBL29370613

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(C4(c5ccc(N(c6ccc(-c7ccccc7)cc6)c6ccc(-c7ccccc7)cc6)cc5)c5ccccc5-c5ccccc54)cc3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
MAPT P10636 3/20 0.52
KDM4E B2RXH2 2/20 0.52
LMNA P02545 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
OPRK1 P41145 1/20 0.52
POLB P06746 1/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
PDK2 Q15119 5/20 0.38
TDP1 Q9NUW8 2/20 0.36
THRB P10828 2/20 0.36
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18287538 1.00 MEN1 (0.52) MEN1KMT2AMAPTKDM4ELMNA
SCHEMBL29547870 1.00 MEN1 (0.52) MEN1KMT2AMAPTKDM4ELMNA
SCHEMBL346270 1.00 MEN1 (0.52) MEN1KMT2AMAPTKDM4ELMNA
SCHEMBL12978444 0.98 MEN1 (0.50) MEN1KMT2AMAPTKDM4ELMNA
SCHEMBL12161497 0.98 MEN1 (0.50) MEN1KMT2AMAPTKDM4ELMNA
SCHEMBL23079433 0.98 MEN1 (0.50) MEN1KMT2AMAPTKDM4ELMNA
SCHEMBL12978469 0.98 MEN1 (0.50) MEN1KMT2AMAPTKDM4ELMNA
SCHEMBL23079515 0.98 MEN1 (0.50) MEN1KMT2AMAPTKDM4ELMNA
SCHEMBL12978438 0.98 MEN1 (0.50) MEN1KMT2AMAPTKDM4ELMNA
SCHEMBL12978428 0.98 MEN1 (0.50) MEN1KMT2AMAPTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024160820-A1 CERIUM-DIKETONATE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS Credoxys GmbH (DE) 2024-08-08 WO claimed
EP-4305681-A1 NEW CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS CREDOXYS GmbH (DE) 2024-01-17 EP claimed
CN-112534596-B Metal organic perovskite solar cell, serial solar cell and manufacturing method thereof 西门子能源全球有限两合公司 2023-09-12 CN claimed
WO-2022189431-A1 NEW CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS Credoxys GmbH (DE) 2022-09-15 WO claimed
EP-4029069-A1 CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS Credoxys GmbH c/o Institut for Applied Physics (DE) 2022-07-20 EP claimed
EP-3321986-B1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO LTD (KR) 2022-04-13 EP claimed
EP-4205191-B1 CHEMICAL COMPOUND, USE OF AT LEAST ONE SUCH CHEMICAL COMPOUND IN AN OPTOELECTRONIC COMPONENT, AND OPTOELECTRONIC COMPONENT CONTAINING AT LEAST ONE SUCH CHEMICAL COMPOUND HELIATEK GMBH (DE) 2026-04-22 EP disclosed
EP-3871279-B1 MULTI-JUNCTION DEVICE PRODUCTION PROCESS OXFORD PHOTOVOLTAICS LTD (GB) 2026-04-01 EP disclosed
EP-4716436-A1 OLED DISPLAY COMPRISING CERIUM-DIKETONATE COMPLEXES AND METHOD TO PRODUCE SUCH AN OLED DISPLAY CREDOXYS GmbH (DE) 2026-03-25 EP disclosed
EP-3667751-B1 PASSIVATION OF METAL HALIDE PEROVSKITES UNIV OXFORD INNOVATION LTD (GB) 2026-03-11 EP disclosed
US-12538704-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2026-01-27 US disclosed
WO-2025229112-A1 LIGHT HARVESTING COMPONENT Credoxys GmbH (DE) 2025-11-06 WO disclosed
EP-4634187-A1 INDACENE AND AZAINDACENE COMPOUNDS AND HIGHER HOMOLOGUES AND THE USE THEREOF Credoxys GmbH (DE) 2025-10-22 EP disclosed
EP-3973580-A1 PHOTODETECTOR WITH IMPROVED DETECTION RESULT Senorics GmbH (DE) 2022-03-30 EP disclosed
EP-3970209-A1 PHOTOVOLTAIC DEVICE Oxford Photovoltaics Limited (GB) 2022-03-23 EP disclosed
EP-3640252-B1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS UDC IRELAND LTD (IE) 2022-03-16 EP disclosed
EP-3398214-B1 ORGANIC SEMICONDUCTING MATERIAL AND USE THEREOF IN ORGANIC DEVICES HELIATEK GMBH (DE) 2022-03-16 EP disclosed
WO-2022042804-A1 CHEMICAL COMPOUND, USE OF AT LEAST ONE SUCH CHEMICAL COMPOUND IN AN OPTOELECTRONIC COMPONENT, AND OPTOELECTRONIC COMPONENT CONTAINING AT LEAST ONE SUCH CHEMICAL COMPOUND HELIATEK GMBH (DE) 2022-03-03 WO disclosed
EP-3345230-B1 DOUBLE PEROVSKITE UNIV OXFORD INNOVATION LTD (GB) 2022-02-09 EP disclosed
CN-114026099-A Compounds having a furopyrrole or thienopyrrole group, optoelectronic components having compounds of this type and the use of compounds of this type in optoelectronic components 赫里亚泰克有限责任公司 2022-02-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12538704-B2 4H-imidazo[1,2-a]imidazoles for electronic applications RIF1, NR2E1, NR3C1 MEN1 1766/4885KMT2A 1240/4885MAPT 4314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.